R Mecklenbrauck

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Venues

Leukemia

This page only lists publications with an associated author ORCID identifier.

Publications

C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)

R Mecklenbrauck.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

R Mecklenbrauck